Efficacy and Safety of Acute Carotid Stenting for Tandem Lesions in Acute Ischemic Stroke: A Multicenter, Real-World Registry Cohort Study
Background Whether to routinely stent extracranial carotid lesions during endovascular thrombectomy (EVT) for anterior circulation tandem lesions remains debated. Because current evidence relies heavily on Western cohorts with different stroke etiologies, we investigated the efficacy and safety of acute extracranial stenting in a real-world Chinese cohort predominantly characterized by atherosclerosis. Methods We retrospectively analyzed patients with anterior circulation tandem lesions treated with EVT within 24 hours of onset across seven comprehensive stroke centers in China (July 2021–December 2023). Patients were stratified into acute stenting and non-stenting groups. Multivariable logistic regression was performed to evaluate 90-day functional independence (modified Rankin Scale [mRS] 0–2), 90-day vascular patency (> 50% residual stenosis), and safety outcomes. Results Of 142 patients (95.8% atherosclerotic etiology), 113 (79.6%) underwent acute stenting and 29 (20.4%) received non-stenting management, with a higher baseline rate of complete extracranial occlusion in the stent group (69.0% vs. 37.9%, p = 0.002). The stent group achieved a higher rate of 90-day functional independence (61.9% vs. 44.8%). After multivariable adjustment, acute stenting was independently associated with improved 90-day functional independence (adjusted odds ratio [aOR] 3.27, 95% CI 1.24–8.66, p = 0.017), markedly reduced > 50% residual stenosis at 90 days (4.6% vs. 32.1%; aOR 0.04, 95% CI 0.01–0.24, p < 0.001), and lower odds of overall in-hospital complications (31.2% vs. 52.0%; aOR 0.34, 95% CI 0.12–1.00, p = 0.049). Complete reperfusion, 48-hour intracranial hemorrhage, and 90-day mortality did not differ significantly between groups. Conclusion In this real-world Chinese cohort, acute extracranial stenting during EVT for tandem lesions improved 90-day functional outcomes and vascular patency while reducing in-hospital complications without increasing bleeding or mortality risks, awaiting confirmation from randomized trials.
Authors
- Tingyu Yi (ORCID: https://orcid.org/0000-0003-3110-5844)
- Jingwei Li (ORCID: https://orcid.org/0000-0002-5341-2776)
- Ke Wang (ORCID: https://orcid.org/0000-0003-2848-2577)
- Jingping Sun (ORCID: https://orcid.org/0000-0002-3051-7399)
- Wenqiang Cai
- Xueli Cai
- Hongxing Han
- Chanjuan Zheng
- Hao Chen
- Wei Hu
Institutions
- Zhangzhou Municipal Hospital of Fujian Province (CN)
- Nanjing Drum Tower Hospital (CN)
- Lishui Central Hospital (CN)
- Guigang City People's Hospital (CN)
- Shandong Provincial Hospital (CN)
- Anhui Provincial Hospital (CN)
Publication Details
- Journal
- Research Square
- Published
- 2026-11-18
- DOI
- https://doi.org/10.21203/rs.3.rs-11547996/v1
- Primary Topic
- Acute Ischemic Stroke Management
- Type
- preprint